SAHPRA
South African Health Products Regulatory Authority
- Website
- sahpra.org.za · all feeds from this site
- Feed URL
https://www.sahpra.org.za/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
SAHPRA calls on patients to report medicine side effects
Pretoria, 4 November 2026 – The South African Health Products Regulatory Authority (SAHPRA) is joining the global #MedSafetyWeek campaign, running from 2 – 8 November. This campaign aims to encourage patients and healthcare professionals to report suspected side effects of…
-
Beyond the Lab: SAHPRA introduces NWU students to careers in Radiation Science and Regulatory Science
19 October 2026 – “I knew about SAHPRA as a regulator, but I did not know about the Radiation Control Unit and the work they do,” reflected a final-year BSc student during the University of North West (NWU)’s School of Physical and Chemical Sciences (SPCS)... The post Beyond the…
-
Important Notice on Cybersecurity Threats
02 October 2026 – The South African Health Products Regulatory Authority (SAHPRA) wishes to alert all stakeholders to phishing emails currently circulating with the subject lines “Urgent” and “Follow-Up”. SAHPRA is aware that some stakeholders have already clicked on links…
-
SAHPRA Reinforces Its Commitment to Radiation Safety at IAEA General Conference
18 September 2026 – The South African Health Products Regulatory Authority (SAHPRA) is participating in the 70th International Atomic Energy Agency (IAEA) General Conference in Vienna, underscoring its critical role in ensuring the safe and responsible use of radiation in…
-
SAHPRA and Lesotho strengthen regional collaboration for regulatory excellence
14 September 2026 – The South African Health Products Regulatory Authority (SAHPRA) hosted a three-day bilateral engagement with Lesotho’s Radiation Protection Agency (RPA) at its Pretoria head office. The meeting promoted knowledge sharing in radiation regulation and regulatory…
-
South Africa Maintains WHO Maturity Level 3 (ML3) for Vaccine Regulation
26 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) is pleased to share that the World Health Organization (WHO) has confirmed that South Africa has achieved and maintained Maturity Level 3 (ML3) for the regulation of vaccines (producing), as of 18…
-
SAHPRA Reaffirms the Safety of Routine Childhood Vaccination
20 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) wishes to reaffirm the public that routine childhood vaccines used in South Africa remain safe based on ongoing evidence and monitoring. SAHPRA continuously monitors the safety and quality of…
-
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Risk of Serious and Fatal Outcomes
20 August 2026 The South African Health Products Regulatory Authority (SAHPRA) wishes to remind healthcare professionals of the risk of angioedema during treatment with angiotensin-converting enzyme (ACE) inhibitors (e.g. captopril, enalapril, lisinopril, perindopril, quinapril,…
-
SAHPRA inspires TUT students to pursue careers in health regulation
Pretoria, 17 August 2026 – Tshwane University of Technology (TUT) Faculty of Science students at the Arcadia Campus filled the Science Hall to welcome the South African Health Products Regulatory Authority (SAHPRA) as part of its ongoing programme to engage university students…
-
SAHPRA recalls certain batches of Enalapril 10mg Arya Commonly used to treat high blood pressure
Pretoria, 16 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) has initiated the recall of four batches of Enalapril 10mg Arya, a medicine commonly used to treat high blood pressure (hypertension), following the identification of out-of-specification…